Bioshares, Australia’s expert biotech newsletter published by Blake Industry & Market Analysis Pty Ltd has announced “Biotech IPO Window: ‘Open’” in its 28th January 2011 Newsletter.
Bioshares reports that Reva Medical and Bioniche both listed and traded at above their listing price. Bioshares said “The IPO window has certainly opened in Australia following massive biotech deals last year and an improved stability in global financial markets.”
January 2011
February 19th, 2011 · No Comments
Tags: news
0 responses so far ↓
There are no comments yet...Kick things off by filling out the form below.
Leave a Comment